Bank of America
DFTX

Bank of America’s Definium Therapeutics DFTX Stock Holding History

Bank of America’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.99M Buy
158,345
+47,878
+43% +$812K ﹤0.01% 3835
2025
Q4 		$1.48M Buy
110,467
+26,456
+31% +$327K ﹤0.01% 4284
2025
Q3 		$990K Sell
84,011
-35,203
-30% -$328K ﹤0.01% 5330
2025
Q2 		$774K Buy
119,214
+30,992
+35% +$204K ﹤0.01% 5457
2025
Q1 		$516K Sell
88,222
-184,707
-68% -$1.32M ﹤0.01% 5632
2024
Q4 		$1.9M Sell
272,929
-39,662
-13% -$273K ﹤0.01% 4492
2024
Q3 		$1.78M Buy
312,591
+236,833
+313% +$1.65M ﹤0.01% 4643
2024
Q2 		$546K Buy
75,758
+49,576
+189% +$434K ﹤0.01% 5284
2024
Q1 		$246K Sell
26,182
-5,860
-18% -$33.4K ﹤0.01% 5781
2023
Q4 		$117K Buy
32,042
+17,103
+114% +$51.5K ﹤0.01% 6313
2023
Q3 		$46.8K Buy
14,939
+3,756
+34% +$15.4K ﹤0.01% 6520
2023
Q2 		$39.9K Buy
11,183
+2,632
+31% +$9.08K ﹤0.01% 6530
2023
Q1 		$27.1K Sell
8,551
-4,535
-35% -$15.1K ﹤0.01% 6669
2022
Q4 		$28.8K Sell
13,086
-42,449
-76% -$118K ﹤0.01% 6638
2022
Q3 		$194K Buy
55,535
+48,463
+685% +$465K ﹤0.01% 6002
2022
Q2 		$68K Buy
7,072
+3,908
+124% +$49.4K ﹤0.01% 6678
2022
Q1 		$52K Sell
3,164
-7,200
-69% -$125K ﹤0.01% 7159
2021
Q4 		$214K Buy
10,364
+7,884
+318% +$252K ﹤0.01% 6463
2021
Q3 		$87K Sell
2,480
-841
-25% -$36.4K ﹤0.01% 6798
2021
Q2 		$172K Buy
+3,321
New +$174K ﹤0.01% 6194

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America's DFTX Position: Q1 2026 in Review

Bank of America increased its Definium Therapeutics (DFTX) stake by 43% in Q1 2026, buying an estimated $812K and bringing the position to 158,345 shares worth $2.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3835.

Bank of America first reported a position in DFTX in Q2 2021 and has held it in 20 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Bank of America held 158,345 shares of Definium Therapeutics worth $2.99M as of Q1 2026.
  • Bank of America bought 47,878 Definium Therapeutics shares in Q1 2026, an estimated $812K.
  • Definium Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3835 holding.
  • Bank of America first reported a position in Definium Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.